Cell Implants Improve Motor Control in Parkinson's Patients

Human retina cell implants improved motor symptomsof Alabama at Birmingham and colleagues conducted
in a group of Parkinson's disease (PD) patients whoan open-label pilot study to evaluate the effect of
participated in a recent study, and they appeared to beunilateral implantation of human RPE cells attached to
safe and well tolerated, according to a report publishedgelatin microcarriers.Six patients with advanced
in the Archives of Neurology.Parkinson's disease is aParkinson's disease received cell implants, which were
neurodegenerative disorder characterized by tremor,inserted into the brain tissue. The researchers
rigidity, postural instability and slowed ability to start andperformed efficacy evaluations at one and three
continue movements. Most patients with PD requiremonths after surgery, and then at six, nine, 12, 15, 18
therapy with the medication levodopa to controland 24 months. Yearly follow-up visits are ongoing and
symptoms three to five years after a diagnosis ofwill continue."The implants were well tolerated," the
PD.Motor FluctuationsHowever, disease progressionauthors report. "We observed an average
and long-term oral treatment with levodopa may leadimprovement of 48 percent at 12 months after
to the development of motor fluctuations and difficultyimplantation in the Unified Parkinson's Disease Rating
in performing voluntary movementsScale motor subscore with the patient in the off state,
(dyskinesias).Human retinal pigment epithelial (RPE) cellswhich was sustained through 24 months."Quality of
produce levodopa and can be isolated fromLife"Improvement was also observed in activities of
post-mortem human eye tissue, grown in culture, anddaily living, quality of life and motor fluctuations. No
implanted into the brain attached to microcarriers. (Theoff-state dyskinesias were observed," they add."On
retinal pigment epithelium is the pigment cell layer foundthe basis of the motor improvement and tolerability
in the inner layer of the retina of the eye.)Theseobserved in this open-label study, a randomized,
implants have been shown to ease motor problems indouble-blind, placebo-controlled study has been initiated
animal models of Parkinson's disease in earlierto more objectively test efficacy and continue to
research, according to the article.48 Percentassess safety," the authors conclude.
ImprovementNatividad P. Stover, MD, of the University